Physician profile
Samuel Walling
NPI 1942731955
$6,743.17
in general payments reported to CMS, 2019-2025
11 companies · $13.76 in 2025
The $13.76 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $346 · 2022: $536 · 2023: $5,488 · 2024: $359 · 2025: $13.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Travel and Lodging: $2,282 · Food and Beverage: $1,078.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Travel and Lodging | $2,282.32 |
| Food and Beverage | $1,078.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,952.45 | 2023-2024 | Davinci Xi, Da Vinci Surgical System |
| Axonics, INC. | $830.29 | 2022-2024 | Axonics, Bulkamid |
| Medical Device Business Services, INC. | $329.00 | 2019 | |
| Medtronic, INC. | $274.21 | 2022 | |
| Davol INC. | $163.34 | 2023 | Phasix Mesh |
| Olympus Corporation of The Americas | $100.99 | 2023 | Evis Exera Lll Colonovideoscope |
| Siemens Medical Solutions USA, INC. | $26.45 | 2024 | Cios Spin |
| Merit Medical Systems INC | $19.25 | 2024 | Savi Scout |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.23 | 2019 | |
| Thd America, INC. | $16.20 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.76 | 2025 | Eohilia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Walling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.